Curapath is a science-driven CDMO specializing in the design, development, and GMP manufacturing of advanced drug delivery systems. We support biopharma companies from early R&D through to commercial production, enabling innovation across every stage. Our expertise lies in non-viral gene delivery, offering polymer and lipid-based nanoparticles tailored for a wide variety of payloads. From excipient synthesis to drug product formulation, our flexible service model and proprietary technologies ensure seamless development. Committed to quality, innovation, and collaboration, we help bring next-generation therapies to market faster.

Download our corporate deck to explore Curapath’s capabilities, platforms, and how we support partners from discovery to commercialization.